How BI Supports Grass Roots Innovation How BI Supports Grass Roots Innovation Hear from life-science entrepreneurs about how we are supporting early-stage science through our innovative Grass Roots program.
"Medical innovations and healthcare for everyone" "Medical innovations and healthcare for everyone" African Americans are often excluded from healthcare options and medical innovations. We want to learn how we can better serve them.
Breakthrough introduction innovation pet parasiticides Breakthrough introduction innovation pet parasiticides In 2014, Boehringer introduced a new product, which became the first in a new class of isoxazoline products for flea and tick protection in dogs.
1990-2023: Value through Innovation 1990-2023: Value through Innovation The Boehringer Ingelheim history from 1990 to 2023, with milestones
Innovation from within Innovation from within Justine Rochon and Marc Weimer talk about the transformation of Biostatistics and Data Sciences (BDS) into a modern organisation in drug development.
Advancing green chemistry for more sustainable medicines Advancing green chemistry for more sustainable medicines By applying the principles of eco-design and green chemistry, we developed an innovative manufacturing process with reduced environmental footprint.
Innovation in medicinal chemistry Innovation in medicinal chemistry Darryl McConnell, Research Site Head, Austria and Jürgen Mack, Medicinal Chemistry, explain how we are working to unlock unsolved diseases
Combating food insecurity for more health equity in the U.S. Combating food insecurity for more health equity in the U.S. Meet social innovation founder Katie at Making More Health Together 2023: How the social innovation founder brings fresh food stores back to the U.S.
Innovation & Opportunity for Tech in Pharma Innovation & Opportunity for Tech in Pharma Boehringer Ingelheim’s Meet & Greet at the Women in Tech Global Conference
Digital innovation: „We change the way labs work“ Digital innovation: „We change the way labs work“ QUDA – an in-house software – changes the way labs work. It increases our quality assurance and our drug saftey.
BI increases commitments to sustainable development BI increases commitments to sustainable development At the World Health Summit 2021, Boehringer Ingelheim announces updates to its strategic approach to sustainable development
Oncology and Cancer Immunology Research Oncology and Cancer Immunology Research Find out more about our research and development in oncology and cancer immunology.
New Partnership to Develop Gene Therapy for Cystic Fibrosis New Partnership to Develop Gene Therapy for Cystic Fibrosis Boehringer Ingelheim steps into the field of gene therapy with experienced partners to jointly develop first gene therapy for cystic fibrosis
Cardio-Renal-Metabolic Research Cardio-Renal-Metabolic Research Read about our patient-centric approach to cardio-renal-metabolic disease research.
Innovating for our business Innovating for our business We drive innovation across our complex business landscape at Boehringer Ingelheim. Technology is an integral part of our core business processes and we focus on advanced technologies.
BIVF funding more than doubled to 250 M€ BIVF funding more than doubled to 250 M€ Boehringer Ingelheim increases funding for its corporate venture fund, the Boehringer Ingelheim Venture Fund (BIVF), from EUR 100 to 250 million
commitments to sustainable development commitments to sustainable development On One Health Day, Boehringer Ingelheim shares an update on its strategic approach to sustainability for employees, partners and wider communities
RE-LY-trial-publication-10-year-anniversary RE-LY-trial-publication-10-year-anniversary Boehringer Ingelheim recognises the contribution made in the decade since the RE-LY® trial publication by patients, HCPs and researchers
Central Nervous System Diseases Central Nervous System Diseases Find out more about our research and development in central nervous system diseases
Immunology Respiratory Research Immunology Respiratory Research Find out more about our research and development in Immunology & Respiratory diseases
FuturePack FuturePack Boehringer Ingelheim has built a new special machine that enables efficient and sustainable packaging of small batches.